Literature DB >> 1852485

Alterations in erythrocyte membrane phospholipid organization due to the intracellular growth of the human malaria parasite, Plasmodium falciparum.

P A Maguire1, J Prudhomme, I W Sherman.   

Abstract

The asymmetric distribution of phospholipids in the erythrocyte membrane during the intracellular development of the human malaria parasite Plasmodium falciparum was studied. Infected cells of high parasitaemia were treated with phospholipase A2 or sphingomyelinase C, followed by isolation of the host red cell membrane using the Affigel (731) bead method. Additionally, phosphatidylserine on the surface of infected cells was probed using a phosphatidylserine-sensitive prothrombinase assay. Trophozoite-infected cells showed an increase in phosphatidylethanolamine and phosphatidylserine and a decrease in phosphatidylcholine in the outer leaflet. In addition to the changes already present in trophozoite-infected cells, schizont-infected cells showed a decrease in sphingomyelin as well as a further increase in phosphatidylserine in the outer leaflet. The results are discussed with respect to possible mechanisms and consequences of these changes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1852485     DOI: 10.1017/s0031182000062466

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  18 in total

Review 1.  Channel-induced apoptosis of infected host cells-the case of malaria.

Authors:  Florian Lang; Philipp A Lang; Karl S Lang; Verena Brand; Valerie Tanneur; Christophe Duranton; Thomas Wieder; Stephan M Huber
Journal:  Pflugers Arch       Date:  2004-03-20       Impact factor: 3.657

2.  In vitro anti-Plasmodium falciparum properties of the full set of human secreted phospholipases A2.

Authors:  Carole Guillaume; Christine Payré; Ikram Jemel; Louise Jeammet; Sofiane Bezzine; Gajendra S Naika; James Bollinger; Philippe Grellier; Michael H Gelb; Joseph Schrével; Gérard Lambeau; Christiane Deregnaucourt
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

3.  High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals.

Authors:  P H Consigny; B Cauquelin; P Agnamey; E Comby; P Brasseur; J J Ballet; C Roussilhon
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 4.  Of membranes and malaria: phospholipid asymmetry in Plasmodium falciparum-infected red blood cells.

Authors:  Merryn Fraser; Kai Matuschewski; Alexander G Maier
Journal:  Cell Mol Life Sci       Date:  2021-03-13       Impact factor: 9.261

5.  Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid.

Authors:  Ravi S Kasinathan; Michael Föller; Saisudha Koka; Stephan M Huber; Florian Lang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-19       Impact factor: 3.000

6.  Increased choline transport in erythrocytes from mice infected with the malaria parasite Plasmodium vinckei vinckei.

Authors:  H M Staines; K Kirk
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

7.  High levels of anti-phospholipid antibodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria.

Authors:  C A Facer; G Agiostratidou
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

Review 8.  Plasmodium falciparum cerebral malaria complicated by disseminated intravascular coagulation and symmetrical peripheral gangrene: case report and review.

Authors:  M E Liechti; V Zumsteg; C F R Hatz; T Herren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

9.  Alterations of uninfected red blood cells in malaria.

Authors:  D Sabolovic; J C Bouanga; M Danis; D Mazier; M Gentilini
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

10.  The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum.

Authors:  Christoph Gelhaus; Thomas Jacobs; Jörg Andrä; Matthias Leippe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.